Latest Oncotype DX Stories
New Data Presented at ASCO® Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy
REDWOOD CITY, Calif., May 23, 2014 /PRNewswire/ -- Genomic Health, Inc.
New Analysis Suggests Oncotype DX Predicts Recurrence Risk After Prostatectomy Regardless of Post-Surgery Treatment REDWOOD CITY, Calif., May 20, 2014 /PRNewswire/ -- Genomic Health,
Oncotype DX® Prostate Cancer Test Enables More Precise Risk Assessment and Significantly Increases Number of Low-Risk Patients Who Can Confidently Choose Active Surveillance REDWOOD
Centralized database of gene-based tests enables easy access to information, improves transparency REDWOOD CITY, Calif., May 14, 2014 /PRNewswire/ -- In response to continued advances
The Diagnostics Marketing Association (DxMA) hosted their annual Global Marketing Summit and Dx Creative Communications Awards Ceremony last month in San Francisco, CA.
13% Increase in Test Volume and 7% Increase in Product Revenue Compared to Prior Year REDWOOD CITY, Calif., May 6, 2014 /PRNewswire/ -- Genomic Health, Inc.
New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/
Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc.
REDWOOD CITY, Calif., April 29, 2014 /PRNewswire/ -- Genomic Health, Inc.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.